100 related articles for article (PubMed ID: 12013785)
21. Elevated cerebrospinal fluid F2-isoprostane levels indicating oxidative stress in healthy siblings of multiple sclerosis patients.
Mattsson N; Haghighi S; Andersen O; Yao Y; Rosengren L; Blennow K; Praticò D; Zetterberg H
Neurosci Lett; 2007 Mar; 414(3):233-6. PubMed ID: 17227694
[TBL] [Abstract][Full Text] [Related]
22. Advances in methods for the determination of biologically relevant lipid peroxidation products.
Spickett CM; Wiswedel I; Siems W; Zarkovic K; Zarkovic N
Free Radic Res; 2010 Oct; 44(10):1172-202. PubMed ID: 20836661
[TBL] [Abstract][Full Text] [Related]
23. [Biomarkers of lipid peroxidation: analytical aspects].
Michel F; Bonnefont-Rousselot D; Mas E; Drai J; Thérond P
Ann Biol Clin (Paris); 2008; 66(6):605-20. PubMed ID: 19091659
[TBL] [Abstract][Full Text] [Related]
24. Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age.
Comporti M; Signorini C; Leoncini S; Buonocore G; Rossi V; Ciccoli L
Free Radic Biol Med; 2004 Sep; 37(5):724-32. PubMed ID: 15288129
[TBL] [Abstract][Full Text] [Related]
25. Elevated F2-isoprostanes in thalassemic patients.
Matayatsuk C; Lee CY; Kalpravidh RW; Sirankapracha P; Wilairat P; Fucharoen S; Halliwell B
Free Radic Biol Med; 2007 Dec; 43(12):1649-55. PubMed ID: 18037130
[TBL] [Abstract][Full Text] [Related]
26. Benefits of prolonged gradient separation for high-performance liquid chromatography-tandem mass spectrometry quantitation of plasma total 15-series F-isoprostanes.
Taylor AW; Bruno RS; Frei B; Traber MG
Anal Biochem; 2006 Mar; 350(1):41-51. PubMed ID: 16448621
[TBL] [Abstract][Full Text] [Related]
27. F2-isoprostanes: potential markers of oxidative stress during resuscitation.
Gutierrez G
Crit Care Med; 2005 Sep; 33(9):2137-8. PubMed ID: 16148502
[No Abstract] [Full Text] [Related]
28. [Programming in the mass spectrometric and chromato-mass spectrometric determination of toxic substances in air].
Dmitriev MT; Rastiannikov EG; Eloian VR
Gig Sanit; 1978 Mar; (3):68-73. PubMed ID: 640414
[No Abstract] [Full Text] [Related]
29. F2-isoprostanes biomarkers of lipid peroxidation: their utility in evaluation of oxidative stress induced by toxic agents.
Piłacik B; Nofer TW; Wasowicz W
Int J Occup Med Environ Health; 2002; 15(1):19-27. PubMed ID: 12038860
[TBL] [Abstract][Full Text] [Related]
30. Simultaneous measurement of F2-isoprostane, hydroxyoctadecadienoic acid, hydroxyeicosatetraenoic acid, and hydroxycholesterols from physiological samples.
Yoshida Y; Kodai S; Takemura S; Minamiyama Y; Niki E
Anal Biochem; 2008 Aug; 379(1):105-15. PubMed ID: 18482573
[TBL] [Abstract][Full Text] [Related]
31. Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.
Himmelfarb J; Phinney S; Ikizler TA; Kane J; McMonagle E; Miller G
J Ren Nutr; 2007 Sep; 17(5):296-304. PubMed ID: 17720098
[TBL] [Abstract][Full Text] [Related]
32. Measurement of F2-isoprostanes, hydroxyeicosatetraenoic products, and oxysterols from a single plasma sample.
Lee CY; Huang SH; Jenner AM; Halliwell B
Free Radic Biol Med; 2008 Apr; 44(7):1314-22. PubMed ID: 18226605
[TBL] [Abstract][Full Text] [Related]
33. Stability of measurements of biomarkers of oxidative stress in blood over 36 hours.
Wu T; Rifai N; Roberts LJ; Willett WC; Rimm EB
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1399-402. PubMed ID: 15298964
[TBL] [Abstract][Full Text] [Related]
34. Markers of oxidative stress in ICU clinical settings: present and future.
Grune T; Berger MM
Curr Opin Clin Nutr Metab Care; 2007 Nov; 10(6):712-7. PubMed ID: 18089952
[TBL] [Abstract][Full Text] [Related]
35. Reproducibility of oxidative stress biomarkers in breath condensate: are they reliable?
Rahman I
Eur Respir J; 2004 Feb; 23(2):183-4. PubMed ID: 14979486
[No Abstract] [Full Text] [Related]
36. Allergen-induced formation of F2-isoprostanes in a murine asthma model identifies oxidative stress in acute airway inflammation in vivo.
Jonasson S; Hjoberg J; Hedenstierna G; Basu S
Prostaglandins Leukot Essent Fatty Acids; 2009 Jan; 80(1):1-7. PubMed ID: 19081714
[TBL] [Abstract][Full Text] [Related]
37. Epidemiological marker for oxidant status: comparison of the ELISA and the gas chromatography/mass spectrometry assay for urine 2,3-dinor-5,6-dihydro-15-F2t-isoprostane.
Il'yasova D; Morrow JD; Ivanova A; Wagenknecht LE
Ann Epidemiol; 2004 Nov; 14(10):793-7. PubMed ID: 15519902
[TBL] [Abstract][Full Text] [Related]
38. Cautions in the use of biomarkers of oxidative damage; the vascular and antioxidant effects of dark soy sauce in humans.
Lee CY; Isaac HB; Wang H; Huang SH; Long LH; Jenner AM; Kelly RP; Halliwell B
Biochem Biophys Res Commun; 2006 Jun; 344(3):906-11. PubMed ID: 16631617
[TBL] [Abstract][Full Text] [Related]
39. Porous graphitic carbon chromatography-tandem mass spectrometry for the study of isoprostanes in human cerebrospinal fluid.
Bohnstedt KC; Karlberg B; Basun H; Schmidt S
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 827(1):39-43. PubMed ID: 16260377
[TBL] [Abstract][Full Text] [Related]
40. Rapid preparation of human urine and plasma samples for analysis of F2-isoprostanes by gas chromatography-mass spectrometry.
Lee CY; Jenner AM; Halliwell B
Biochem Biophys Res Commun; 2004 Jul; 320(3):696-702. PubMed ID: 15240104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
